23 May 2013
Keywords: lab21, ramps, up, kras, egfr, testing, capacity
Article | 28 July 2008
Lab21, a UK-based provider of health care diagnostic products and services, has launched K-RAS gene mutation and epidermal growth factor
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 July 2008
22 May 2013
© 2013 thepharmaletter.com